P. Gregor

发表

What's new in the prevention of infective endocarditis?

P. Gregor, 2013 .

Nebivolol in the treatment of cardiac failure: a double-blind controlled clinical trial.

L. Špinarová, I. Málek, J. Vojáček, 1997, Journal of cardiac failure.

(Reverse Takotsubo syndrome, a rare form of "Broken Heart" syndrome)

Z. Stelmach, P. Gregor, O. Ioniţă, 2020 .

Low prevalence and variable clinical presentation of troponin I and troponin T gene mutations in hypertrophic cardiomyopathy.

M. Penicka, J. Veselka, P. Widimsky, 2009, Genetic testing and molecular biomarkers.

Our initial experience with genetic testing of patients with hypertrophic cardiomyopathy: mutations of troponin T and troponin I genes

M. Penicka, K. Curila, H. Línková, 2008 .

Identification of hibernating myocardium with myocardial contrast echocardiography: comparison with late gadolinium-enhanced magnetic resonance.

M. Penicka, J. Tintera, H. Línková, 2008, International journal of cardiology.

Inter-hospital transport for primary angioplasty does not compromise left ventricular function: six-month echocardiographic follow-up of the PRAGUE 1 Study.

M. Aschermann, P. Widimsky, H. Línková, 2003, Japanese heart journal.

Pericardial involvement during the course of myocardial infarction. A long-term clinical and echocardiographic study.

P. Widimsky, P. Gregor, 1995, Chest.

Recent atrial fibrillation in acute myocardial infarction: a sign of pericarditis.

P. Widimsky, P. Gregor, 1993, Cor et vasa.

Prophylaxis for infective endocarditis - an endless story with a colorful past, an uncertain presence and unclear future.

P. Gregor, 2019, Vnitrni lekarstvi.

Hemodynamic effects of disopyramide at rest and during exercise in normal subjects.

J. Parker, U. Thadani, R. West, 1981, Catheterization and cardiovascular diagnosis.

[Tachycardia-induced cardiomyopathy].

P. Gregor, R. Jirmář, V. Bufka, 2010, Casopis lekaru ceskych.

Spectrum and clinical manifestations of mutations in genes responsible for hypertrophic cardiomyopathy

M. Penicka, J. Veselka, P. Widimsky, 2012, Acta cardiologica.

Anti-calreticulin antibodies and calreticulin in sera of patients diagnosed with dilated or hypertrophic cardiomyopathy

K. Curila, V. Hábová, D. Sánchez, 2016, Autoimmunity.

Genetic Testing in the Management of Relatives of Patients with Hypertrophic Cardiomyopathy (echocardiography/DNAsequenceanalysis/cardiomyopathies)

M. Penicka, J. Veselka, P. Tomašov, 2014 .

741 Assessment of myocardial viability by contrast echocardiography in patients with chronic ischemic left ventricle dysfunction. Comparison with late gadolinium-enhanced cardiovascular magnetic resonance

M. Penicka, J. Tintera, P. Toušek, 2005 .

Imaging methods in cardiomyopathies

P. Gregor, H. Linkova, 2017 .

treatment of hypertrophic cardiomyopathy – What do we know about it today ? )

K. Curila, P. Gregor, K. Čurila, 2015 .

Pericardial Effusion as a Consequence of Acute Myocardial Infarction

P. Widimsky, P. Gregor, 1999, Echocardiography.

The Appearance and Disappearance Time of Effusions * Table 4 . Relation Between the Size of Effusion and Clinical Signs of Pericarditis *

P. Widimsky, P. Gregor, 2022 .

Hypertrophic cardiomyopathy and sports

P. Gregor, 2015 .

Molecular genetics in hypertrophic cardiomyopathy

M. Penicka, K. Curila, J. Knot, 2007 .

Hypertrophic cardiomyopathy—What is new?

K. Curila, P. Gregor, K. Čurila, 2012 .

Electrocardiographic changes can precede the development of myocardial hypertrophy in the setting of hypertrophic cardiomyopathy.

P. Widimsky, P. Gregor, V. Červenka, 1989, International journal of cardiology.

Hypertrofické kardiomyopatie – co je nového ? ( Hypertrophic cardiomyopathy – what is new ? )

P. Gregor, 2013 .

Cardioprotective effects of adenosine transport inhibition during reversible ischaemia in patients with coronary artery disease.

J. Ottervanger, H. Suryapranata, F. Zijlstra, 1999, International journal of cardiovascular interventions.

Echocardiography in sarcoidosis.

P. Widimsky, T. Sládková, P. Gregor, 1984, Japanese heart journal.

2015 ESC Guidelines for the management of infective endocarditis. Summary document prepared by the Czech Society of Cardiology

K. Linhartová, P. Gregor, J. Beneš, 2016 .

Echocardiographic picture in diabetes mellitus.

P. Widimsky, P. Gregor, Petr Widimsky, 1984, Japanese heart journal.

Variants in miRNA Regulating Cardiac Growth Are Not a Common Cause of Hypertrophic Cardiomyopathy

J. Veselka, P. Widimsky, P. Tomašov, 2015, Cardiology.

Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF)

P. Ponikowski, S. Solomon, M. Pfeffer, 2013, European journal of heart failure.

The effects of candesartan on left ventricular hypertrophy and function in nonobstructive hypertrophic cardiomyopathy: a pilot, randomized study.

M. Penicka, P. Gregor, D. Marek, 2009, The Journal of molecular diagnostics : JMD.

First month course of left ventricular asynergy after intracoronary thrombolysis in acute myocardial infarction. A longitudinal echocardiographic study.

P. Widimsky, T. Sládková, P. Gregor, 1985, European heart journal.

Comparison of Long-Term Effect of Dual-Chamber Pacing and Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy

J. Veselka, J. Krejčí, D. Zemánek, 2013, TheScientificWorldJournal.

[Thoughts about valvular abnormalities yesterday and today].

P. Gregor, H. Linkova, 2018, Vnitrni lekarstvi.

Myocardial viability and cardiac dyssynchrony as strong predictors of perioperative mortality in high-risk patients with ischemic cardiomyopathy having coronary artery bypass surgery.

M. Penicka, J. Bartunek, P. Gregor, 2009, The Journal of thoracic and cardiovascular surgery.

Papillary fibroelastoma of the aortic valve

P. Gregor, E. Paskova, H. Linkova, 2011 .

The effects of candesartan on left ventricular hypertrophy and function in nonobstructive hypertrophic cardiomyopathy: a pilot, randomized study.

M. Penicka, P. Gregor, D. Marek, 2009, The Journal of molecular diagnostics : JMD.

Genetic testing in the management of relatives of patients with hypertrophic cardiomyopathy.

M. Penicka, J. Veselka, P. Tomašov, 2014, Folia biologica.

[Determination of anti-arrhythmia therapy of ventricular arrhythmias based on programmed ventricular stimulation].

M. Herold, P. Osmera, P. Gregor, 1991, Vnitrni lekarstvi.